Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 3/20 | 0.58 |
| ▸ | PI4K2B | Q8TCG2 | 3/20 | 0.58 |
| ▸ | PI4K2A | Q9BTU6 | 3/20 | 0.58 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 1/20 | 0.58 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | GAPDH | P04406 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL580228 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL7746165 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Adenine SCHEMBL7624128 | 1.00 | PI4KA (0.58) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Dextrose SCHEMBL7886725 | 0.99 | PI4KA (0.56) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL8605925 | 0.84 | ADK (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL12542065 | 0.84 | HSD17B10 (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL1531264 | 0.84 | HSD17B10 (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL17824409 | 0.84 | ADK (0.40) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL7680729 | 0.84 | CYP3A4 (0.39) | PI4KAPI4K2BPI4K2API4KBLMNA | |
| Ribose (Furanose) SCHEMBL831005 | 0.84 | CYP3A4 (0.39) | PI4KAPI4K2BPI4K2API4KBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2593 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083840-A1 | METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY | PREC BIOLOGICS INC (US) | 2026-03-26 | — | — | US | claimed |
| WO-2026043843-A1 | TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2026-02-26 | — | — | WO | claimed |
| WO-2025034898-A1 | GASTRIC CANCER PATIENT CLASSIFICATION AND METHODS OF TREATMENT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-02-13 | — | — | WO | claimed |
| CN-119403836-A | Methods for eliminating myeloid-derived suppressor cells using NEO-201 antibodies | 精密生物制品股份有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-4499710-A1 | METHODS FOR ABLATING MYELOID DERIVED SUPPRESSOR CELLS USING NEO-201 ANTIBODY | Precision Biologics, Inc. (US) | 2025-02-05 | — | — | EP | claimed |
| US-20240400714-A1 | METHODS AND COMPOSITIONS FOR TARGETING TREG CELLS | PREC BIOLOGICS INC (US) | 2024-12-05 | — | — | US | claimed |
| US-20240384003-A1 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | PREC BIOLOGICS INC (US) | 2024-11-21 | — | — | US | claimed |
| WO-2024215771-A1 | SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES | SOUTHERN RESEARCH INSTITUTE (US) | 2024-10-17 | — | — | WO | claimed |
| CN-112041343-B | Methods and compositions for targeting Treg cells | 精密生物制品股份有限公司 | 2024-08-30 | — | — | CN | claimed |
| US-12037410-B2 | Methods and compositions for targeting Treg cells | PRECISION BIOLOGICS, INC. (US) | 2024-07-16 | — | — | US | claimed |
| EP-0437563-B1 | BIOLOGICALLY ACTIVE DRUG POLYMER DERIVATIVES | DEBIO RECH PHARMA SA (CH) | 1995-02-22 | — | — | EP | claimed |
| US-5276020-A | Viricides with glycoside structure | EFAMOL HOLDINGS PLC (GB) | 1994-01-04 | — | — | US | claimed |
| EP-0197718-B1 | New medicaments for topical use | FIDIA SPA (IT) | 1993-12-15 | — | — | EP | claimed |
| WO-1993023094-A1 | USE OF HYDROGELS TO FIX BONE REPLACEMENTS | M.U.R.S.T., ITALIAN MINISTRY FOR UNIVERSITIES AND SCIENTIFIC AND TECHNOLOGICAL RESEARCH (IT) | 1993-11-25 | — | — | WO | claimed |
| WO-1993018763-A1 | COMPOSITIONS OF N-(PHOSPHONOACETYL)-L-ASPARTIC ACID AND METHODS OF THEIR USE AS BROAD SPECTRUM ANTIVIRALS | U.S. BIOSCIENCE, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| EP-0555898-A2 | Medicaments for non-topical use | FIDIA S.p.A. (IT) | 1993-08-18 | — | — | EP | claimed |
| WO-1992018517-A1 | METHOD OF TREATING OR PREVENTING HEPATITIS B VIRUS | YALE UNIVERSITY (US) | 1992-10-29 | — | — | WO | claimed |
| US-4736024-A | Process for preparing salt of hyaluronic acid with a pharmaceutically active substance | FIDIA, S.P.A. (IT) | 1988-04-05 | — | — | US | claimed |
| EP-0197718-A2 | New medicaments for topical use | FIDIA S.p.A. (IT) | 1986-10-15 | — | — | EP | claimed |
| EP-0189629-A1 | Method of treatment of viral diseases in plants utilizing ribavirin | VIRATEK, INC. (US) | 1986-08-06 | — | — | EP | claimed |